Abstract
Exposure of mouse peritoneal neutrophils to hypomagnetic conditions (magnetic shielding, a residual static magnetic field of 20 nT) for 1.5 h decreased the level of intracellular reactive oxygen species as recorded by changes in the fluorescence intensity of 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123 oxidation products. The effect of a hypomagnetic field was similarly observed after adding a respiratory burst activator (the formylated peptide N-formyl–Met–Leu–Phe or phorbol 12-meristate-13-acetate) to a low concentration.
Similar content being viewed by others
Abbreviations
- ROS:
-
reactive oxygen species
- H2DCF-DA:
-
2,7-dichlorodihydrofluorescein diacetate
- fMLF:
-
N-formyl–Met–Leu–Phe
- PMA:
-
phorbol 12-meristate-13-acetate
References
V. V. Novikov, V. O. Ponomarev, G. V. Novikov, et al., Biophysics (Moscow) 55 (4), 565 (2010).
V. N. Binhi, Principles of Electromagnetic Biophysics (Fizmatlit, Moscow, 2011) [in Russian].
M. O. Mattsson and M. Simko, Front. Public Health 2, 132 (2014).
F. S. Barnes and B. Greenebaum, Bioelectromagnetics 36, 45 (2015).
V. V. Novikov, E. V. Yablokova, and E. E. Fesenko, Biophysics (Moscow) 60 (3), 429 (2015).
V. V. Novikov, E. V. Yablokova, and E. E. Fesenko, Biophysics (Moscow) 61 (1), 105 (2016).
V. V. Novikov, E. V. Yablokova, and E. E. Fesenko, Biophysics (Moscow) 61 (3), 429 (2016).
V. V. Novikov, E. V. Yablokova, and E. E. Fesenko, Biophysics (Moscow) 61 (6), 959 (2016).
V. V. Novikov, E. V. Yablokova, G. V. Novikov, and E. E. Fesenko, Biophysics (Moscow) 62 (5), 759 (2017).
V. V. Novikov, E. V. Yablokova, and E. E. Fesenko, Biophysics (Moscow) 62 (3), 440 (2017).
V. V. Novikov, E. V. Yablokova, and E. E. Fesenko, Biophysics (Moscow) 63 (2), 277 (2018).
V. N. Binhi and F. S. Prato, PLoS One 12 (6), e0179340 (2017).
J. P. Crow, Nitric Oxide Biol. Chem. 1 (2), 145 (1997).
S. L. Hempel, G. R. Buettner, Y. Q. O’Malley, et al., Free Radic. Biol. Med. 27 (1–2), 146 (1999).
G. Bartosz, Clin. Chim. Acta 368, 53 (2006).
M. Freitas, J. L. Lima, and E. Fernandes, Anal. Chim. Acta 649, 8 (2009).
N. N. Vorob’eva, Immunologiya 34 (4), 227 (2013).
D. I. Brown and K. K. Griendling, Free Radic. Biol. Med.47, 1239 (2009).
R. Korhonen, A. Lahti, H. Kankaanranta, et al., Curr. Drug Targets Inflamm. Allergy 4, 471 (2005).
G. Fossati, D. A. Moulding, D. G. Spiller, et al., J. Immunol. 170, 1964 (2003).
D. I. Roshchupkin, N. S. Belakina, and M. A. Murina, Biophysics (Moscow) 51, 79 (2006).
Yu. A. Vladimirov and E. V. Proskurina, Usp. Biol. Khim. 49, 341 (2009).
A. N. Mayanskii, Tsitokiny i Vospalenie 6 (3), 3 (2007).
P. V. Vignais, Cell. Mol. Life Sci. 59, 1428 (2002).
J. El-Benna, P. M. Dang, and M. A. Gougerot-Pocidalo, Semin. Immunopathol. 30, 279 (2008).
V. V. Novikov and M. N. Zhadin, Biofizika 39 (1), 45 (1994).
V. V. Novikov and E. E. Fesenko, Biophysics (Moscow) 46 (2), 233 (2001).
V. V. Novikov, G. V. Novikov, and E. E. Fesenko, Bioelectromagnetics 30, 343 (2009).
H. Zhang, Z. Zhang, W. Mo, et al., Protein Cell 8 (7), 527 (2017).
C. F. Martino and P. R. Castello, PLoS ONE 6 (8), e22753 (2011).
P. Politanski, E. Rajkowska, M. Brodecki, et al., Bioelectromagnetics 34, 333 (2013).
V. V. Novikov, I. M. Sheiman, and E. E. Fesenko, Biophysics (Moscow) 52 (5), 498 (2007).
V. V. Novikov, I. M. Sheiman, and E. E. Fesenko, Bioelectromagnetics 29, 387 (2008).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.V. Novikov, E.V. Yablokova, E.E. Fesenko, 2018, published in Biofizika, 2018, Vol. 63, No. 3, pp. 484–488.
Rights and permissions
About this article
Cite this article
Novikov, V.V., Yablokova, E.V. & Fesenko, E.E. The Effect of a “Zero” Magnetic Field on the Production of Reactive Oxygen Species in Neutrophils. BIOPHYSICS 63, 365–368 (2018). https://doi.org/10.1134/S000635091803017X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S000635091803017X